Sarepta Therapeutics Inc (NASDAQ: SRPT) kicked off on Friday, up 3.38% from the previous trading day, before settling in for the closing price of $110.50. Over the past 52 weeks, SRPT has traded in a range of $78.67-$173.25.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 32.89% annually for the last half of the decade. While this was happening, its average annual earnings per share was recorded 138.02%. With a float of $89.56 million, this company’s outstanding shares have now reached $93.73 million.
In an organization with 1314 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 85.39%, operating margin of 4.94%, and the pretax margin is 7.89%.
Sarepta Therapeutics Inc (SRPT) Insider Updates
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Sarepta Therapeutics Inc is 6.25%, while institutional ownership is 90.51%. The most recent insider transaction that took place on Aug 30 ’24, was worth 822,100. In this transaction Chief Financial Officer of this company sold 5,985 shares at a rate of $137.36, taking the stock ownership to the 33,946 shares. Before that another transaction happened on Aug 30 ’24, when Company’s Officer proposed sale 5,985 for $137.37, making the entire transaction worth $822,130.
Sarepta Therapeutics Inc (SRPT) Performance Highlights and Predictions
In the latest quarterly report, which was put into the public domain on 9/30/2024, the organization reported 0.82 earnings per share (EPS), higher than consensus estimate (set at 0.37) by 0.45. Wall Street market experts anticipate that the next fiscal year will bring earnings of 2.64 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 138.02% per share during the next fiscal year.
Sarepta Therapeutics Inc (NASDAQ: SRPT) Trading Performance Indicators
Take a look at Sarepta Therapeutics Inc’s (SRPT) current performance indicators. Last quarter, stock had a quick ratio of 3.03. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 6.88.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 1.20, a number that is poised to hit 1.54 in the next quarter and is forecasted to reach 11.33 in one year’s time.
Technical Analysis of Sarepta Therapeutics Inc (SRPT)
Let’s dig in a bit further. During the last 5-days, its volume was 1.06 million. That was inferior than the volume of 1.23 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 52.05%. Additionally, its Average True Range was 4.37.
During the past 100 days, Sarepta Therapeutics Inc’s (SRPT) raw stochastic average was set at 22.89%, which indicates a significant decrease from 39.15% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 46.54% in the past 14 days, which was higher than the 31.24% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $122.00, while its 200-day Moving Average is $130.02. However, in the short run, Sarepta Therapeutics Inc’s stock first resistance to watch stands at $115.87. Second resistance stands at $117.52. The third major resistance level sits at $120.20. If the price goes on to break the first support level at $111.54, it is likely to go to the next support level at $108.86. Assuming the price breaks the second support level, the third support level stands at $107.21.
Sarepta Therapeutics Inc (NASDAQ: SRPT) Key Stats
The company with the Market Capitalisation of 11.28 billion has total of 95,520K Shares Outstanding. Its annual sales at the moment are 1,243 M in contrast with the sum of -535,980 K annual income. Company’s last quarter sales were recorded 467,170 K and last quarter income was 33,610 K.
